Sarilumab (Kevzara) Gets Gets FDA Approval For Polymyalgia Rheumatica

Sarilumab (Kevzara) Gets Gets FDA Approval For Polymyalgia Rheumatica

The US Food and Drug Administration (FDA) approved sarilumab (Kevzara) today for the treatment of polymyalgia rheumatica (PMR) in adults who have…

Read More »